Huilin Hu

home / authors / huilin-hu

Articles

14 Outcomes With First-Line (1L) Ribociclib (RIB) + Endocrine Therapy (ET) vs Physician’s Choice Combination Chemotherapy (combo CT) by Age in Pre/Perimenopausal Patients (pts) With Aggressive HR+/HER2– Advanced Breast Cancer (ABC): A Subgroup Analysis of the RIGHT Choice Trial

14 Outcomes With First-Line (1L) Ribociclib (RIB) + Endocrine Therapy (ET) vs Physician’s Choice Combination Chemotherapy (combo CT) by Age in Pre/Perimenopausal Patients (pts) With Aggressive HR+/HER2– Advanced Breast Cancer (ABC): A Subgroup Analysis of the RIGHT Choice Trial

Nagi El Saghir;Yoon Sim Yap;Yesim Eralp;Seock-Ah Im;Hamdy Abdel Azim;Julie Rihani;Nikita Volkov;Shin-Cheh Chen;Hakan Harputluoglu;Patrapim Sunpaweravong;Yuan-Ching Chang;Teresa Delgar Alfaro;Jiwen Wu;Huilin Hu;Melissa Gao;Yen-Shen Lu
August 15th 2024
19 Efficacy, Safety, and Quality of Life With Ribociclib + Endocrine Therapy in Elderly Patients With HR+/HER2– Advanced Breast Cancer Across the MONALEESA-2, -3, and -7 Trials

19 Efficacy, Safety, and Quality of Life With Ribociclib + Endocrine Therapy in Elderly Patients With HR+/HER2– Advanced Breast Cancer Across the MONALEESA-2, -3, and -7 Trials

Lowell Hart;Seock-Ah Im;Sara M. Tolaney, MD, MPH;Mario Campone;Timothy Pluard;Berta Sousa;Gilles Freyer;Thomas Decker;Kevin Kalinsky, MD, MS;Astrid Thuerigen;Melissa Gao;Huilin Hu;Sherko Kümmel
August 9th 2024

Latest Updated Articles

NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Patient With History of COPD Presents With Abdominal Pain
Published: December 1st 2016 | Updated: September 19th 2024
Patient With History of COPD Presents With Abdominal Pain
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes
Published: August 26th 2011 | Updated: September 19th 2024
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes
45-Year-Old Female With Gross Hematuria Post Partial Nephrectomy
Published: March 1st 2018 | Updated: September 19th 2024
45-Year-Old Female With Gross Hematuria Post Partial Nephrectomy